中国戊肝疫苗:公共卫生专业人员对疫苗推广与防控策略的看法
受访者讨论公私机构在戊肝疫苗推广中的角色、高效推广方式及合理防控目标,强调公共部门信息来源可信、社交媒体可传播信息但需防假新闻,疫苗推广受政府、医院和接种中心知识水平有限制约。结论认为即使有限推广也可提供长期安全性信息并促进高发病率地区采用。
要点
- 公共卫生专业人员认为公共部门是可信的疫苗信息来源,私营疫苗公司也可传播信息。
- 微信等社交媒体可传播疫苗文章,但网民担忧假新闻扩散。
- 政府、医院和公共卫生接种中心知识水平有限制约疫苗推广。
核心结论
- 中国戊肝疫苗推广受政府、医院和公共卫生接种中心知识水平有限制约,但有限推广可提供长期安全性信息并促进高发病率地区采用。
主要发现
- 受访者讨论三大主题:明确公私机构在戊肝疫苗推广营销中的角色责任、识别最有效推广方法、制定合理现实的戊肝防控目标。
- 受访者强调公共部门来源信息可信,私营疫苗公司也可传播信息,微信等社交媒体可传播文章但网民担忧假新闻。
- 疫苗推广受政府、医院和公共卫生接种中心知识水平有限制约。
临床怎么用
- 公共卫生专业人员可依托公共部门可信来源传播戊肝疫苗信息,并利用微信等社交媒体扩散文章同时警惕假新闻。
- 需提升政府、医院和公共卫生接种中心对戊肝疫苗的知识水平以解除推广制约。
- 可考虑在特定工作场所或特定人群等有限 settings 推广戊肝疫苗以积累长期安全性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A hepatitis E (HepE) vaccine was developed and released in China in 2011. Uptake is currently very limited. The aims of this study were to characterize what public health professionals thought about promoting the HepE vaccine in Shanghai, China, and to develop realistic goals for the HepE vaccine based on this information. METHODS: Public health professionals from Shanghai and other jurisdictions of China were contacted to participate in in-depth qualitative interviews between October 2017 and August 2018. Participants were asked about their perception of the HepE vaccine roll-out. Codes were initially based on the structure of the questionnaire. Subsequently, similar ideas were further developed into themes based on what was present in the transcript data. RESULTS: Thirty-five individuals participated. Major topics of discussion included (1) clarifying the roles and responsibilities of private and public institutions in promoting and marketing the HepE vaccine, (2) identifying what methods of promotion were most efficient, and, (3) endeavoring to formulate a reasonable and realistic goal, if any, for HepE prevention and control in China. Participants emphasized that public sector sources can be trusted sources of information (although the private vaccination company can also be useful in disseminating information) and social media such as WeChat can be good ways to disseminate articles (although netizens may be worried about the spread of fake news). Vaccine promotion is restrained given limited levels of knowledge in the government, hospitals, and public health vaccination centers. CONCLUSION: Successful promotion and use of this vaccine in China, even in limited settings (for instance, certain workplaces, or certain groups) could provide additional information on long-term safety and could promote its adoption in other regions of the world where HepE has high morbidity among pregnant women and other populations.
引用
- Chen XX, Wagner AL, Zheng XB, et al. Hepatitis E vaccine in China: Public health professional perspectives on vaccine promotion and strategies for control. Vaccine. 2019. PMID: 31353258. doi:10.1016/j.vaccine.2019.07.067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。